Deficient ADAMTS13 activity leads to thrombotic thrombocytopenic purpura (TTP), which is either congenital (due to mutations) (Levy et al., 2001) or acquired (due to inhibitory antibodies) (Tsai and Lian, 1998). Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.